A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome

NCT02328950 · clinicaltrials.gov ↗

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes
Leukemia, Myeloid, Acute
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Interventions

DRUG: Fludarabine and Cytarabine followed by IV busulfan and cyclophosphamide

Sponsor

Fujian Medical University